| Literature DB >> 33659936 |
Ioannis Leontsinis1, Manos Mantzouranis1, Panagiotis Tsioufis1, Ioannis Andrikou1, Costas Tsioufis1.
Abstract
Hypertension remains a leading risk factor for cardiovascular mortality and morbidity globally despite the availability of effective and well-tolerated antihypertensive medications. Accumulating evidence suggests a more aggressive blood pressure regulation aimed at lower targets, particularly for selected patient groups. Our concepts of the optimal method for blood pressure measurement have radically changed, maintaining appropriate standard office measurements for initial assessment but relying on out-of-office measurement to better guide our decisions. Thorough risk stratification provides guidance in decision making; however, an individualized approach is highly recommended to prevent overtreatment. Undertreatment, on the other hand, remains a major concern and is mainly attributed to poor adherence and resistant or difficult-to-control forms of the disease. This review aims to present modern perspectives, novel treatment options, including innovative technological applications and developing interventional and pharmaceutical therapies, and the major concerns emerging from several years of research and epidemiological observations related to hypertension management. Copyright:Entities:
Keywords: difficult to treat hypertension; hypertension; hypertension management; neuromodulation; novel antihypertensives; resistant hypertension
Year: 2020 PMID: 33659936 PMCID: PMC7894269 DOI: 10.12703/b/9-4
Source DB: PubMed Journal: Fac Rev ISSN: 2732-432X